Oral spironolactone offers an alternative for chronic CSR
- Posted on: May 14 2019
- Leave a response
Investigators retrospectively compared visual and anatomical outcomes among chronic central serous chorioretinopathy (CSR) patients treated with oral spironolactone or half-dose photodynamic therapy (PDT).
Source: AAO
Posted in: Uncategorized